Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects
Status:
Completed
Trial end date:
2018-07-31
Target enrollment:
Participant gender:
Summary
An open-label, randomized, single-dose, two-period, two-group, crossover study was conducted
in 48 healthy Chinese volunteers under fasted or fed conditions (24 volunteers for each
condition) to assess the bioequivalence between two formulations of Sitagliptin
Phosphate/metformin Hydrochloride Tablets.